JBCHEPHARM Total Current Liabilities from 2010 to 2025

JBCHEPHARM   1,746  24.00  1.39%   
JB Chemicals' Total Current Liabilities is increasing with slightly volatile movements from year to year. Total Current Liabilities is estimated to finish at about 10.5 B this year. Total Current Liabilities is the total amount of liabilities that JB Chemicals Pharmaceuticals is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
2010-12-31
Previous Quarter
10 B
Current Value
10.5 B
Quarterly Volatility
2.9 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check JB Chemicals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among JB Chemicals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 B, Interest Expense of 535.3 M or Total Revenue of 41.6 B, as well as many indicators such as . JBCHEPHARM financial statements analysis is a perfect complement when working with JB Chemicals Valuation or Volatility modules.
  
This module can also supplement various JB Chemicals Technical models . Check out the analysis of JB Chemicals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in JBCHEPHARM Stock

JB Chemicals financial ratios help investors to determine whether JBCHEPHARM Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in JBCHEPHARM with respect to the benefits of owning JB Chemicals security.